A surrogate ELISA to select high titer human convalescent plasma for treating immunocompromised patients infected with SARS-CoV-2 variants of concern

Here, the authors review a surrogate ELISA to select COVID-19 convalescent plasma samples that will guarantee a protective level of neutralizing antibodies as the main correlate of protection.

本研究中，作者综述了一种替代酶联免疫吸附试验（surrogate ELISA），用于筛选可确保具备保护性中和抗体水平的新型冠状病毒肺炎（COVID-19）恢复期血浆样本，该中和抗体水平即为保护作用的主要相关性指标。